Summit Securities Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.32K | Buy |
+229
| New | +$6.32K | ﹤0.01% | 823 |
|
|
2024
Q3 | – | Sell |
-51
| Closed | -$6K | – | 637 |
|
|
2024
Q2 | $6K | Buy |
+51
| New | +$6K | ﹤0.01% | 357 |
|
|
2024
Q1 | – | Sell |
-31
| Closed | -$3K | – | 577 |
|
|
2023
Q4 | $3K | Sell |
31
-1,012
| -97% | -$97.9K | ﹤0.01% | 404 |
|
|
2023
Q3 | $108K | Buy |
1,043
+482
| +86% | +$49.9K | 0.01% | 95 |
|
|
2023
Q2 | $68K | Buy |
+561
| New | +$68K | 0.01% | 234 |
|
|
2022
Q4 | – | Sell |
-1,456
| Closed | -$172K | – | 1037 |
|
|
2022
Q3 | $172K | Buy |
+1,456
| New | +$172K | 0.01% | 283 |
|
|
2022
Q2 | – | Sell |
-1,801
| Closed | -$310K | – | 861 |
|
|
2022
Q1 | $310K | Buy |
+1,801
| New | +$310K | 0.03% | 178 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 428 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 418 |
|
|
2021
Q1 | – | Sell |
-12,200
| Closed | -$1.28M | – | 354 |
|
|
2020
Q4 | $1.28M | Buy |
+12,200
| New | +$1.28M | 0.11% | 78 |
|